Skip to content

MiMedx Group MDXG Current Debt

Current Debt at other companies

IAR
Integra LifeSciencesIART
$53.28M+37.5%
Artivion logo
ArtivionAORT
$0-100%
Solventum logo
SolventumSOLV
$505M+405%
Vericel logo
VericelVCEL
$116K0.0%
Enovis logo
EnovisENOV
$35M+74.8%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.18B+96.0%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's current debt?
MiMedx Group (MDXG) reported current debt of $1.5M in Q1 2026.
How has MiMedx Group's current debt changed year-over-year?
MiMedx Group's current debt increased by 33.3% year-over-year, from $1.13M to $1.5M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.